Compare JVA & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JVA | BEAT |
|---|---|---|
| Founded | 1971 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6M | 23.9M |
| IPO Year | 1997 | 2021 |
| Metric | JVA | BEAT |
|---|---|---|
| Price | $5.05 | $0.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 65.8K | ★ 16.3M |
| Earning Date | 09-11-2026 | 11-12-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $90,655,294.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,197.12 |
| P/E Ratio | $7.55 | ★ N/A |
| Revenue Growth | ★ 17.54 | N/A |
| 52 Week Low | $2.93 | $0.36 |
| 52 Week High | $5.18 | $4.00 |
| Indicator | JVA | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 67.45 | 62.01 |
| Support Level | $4.17 | $0.49 |
| Resistance Level | N/A | $0.63 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 84.78 | 83.06 |
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.